Vestmark Advisory Solutions’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.78M | Buy |
1,339,139
+632,900
| +90% | +$3.2M | 0.1% | 154 |
|
|
2025
Q1 | $3.74M | Sell |
706,239
-138,915
| -16% | -$735K | 0.1% | 244 |
|
|
2024
Q4 | $6.36M | Buy |
845,154
+112,221
| +15% | +$844K | 0.22% | 92 |
|
|
2024
Q3 | $4.83M | Sell |
732,933
-51,964
| -7% | -$342K | 0.18% | 115 |
|
|
2024
Q2 | $5.89M | Sell |
784,897
-115,122
| -13% | -$863K | 0.25% | 86 |
|
|
2024
Q1 | $8.97M | Buy |
900,019
+427,763
| +91% | +$4.26M | 0.39% | 55 |
|
|
2023
Q4 | $4.66M | Buy |
+472,256
| New | +$4.66M | 0.24% | 102 |
|